HB Investment

HB Investment Inc., founded on November 11, 1999, is a Seoul-based venture capital firm with an initial capital of KRW 10 billion. The firm focuses on investing in small and medium-sized enterprises that demonstrate potential for steady growth and profitability. In addition to financial investment, HB Investment provides a range of consulting services to support the growth of its portfolio companies. The firm's investment portfolio is diverse, encompassing various sectors, including gaming, entertainment, and high-tech industries such as semiconductors, the Internet, LCD technology, smartphones, and healthcare. Over the years, HB Investment has gained experience in successfully implementing business strategies and has organized several partnership funds to enhance its investment capabilities.

Sung Hwan Bae

Director, Investment Review

Seong-Hwan Bae

Director

Young-Keun Choi

Director at Venture Investment Division

Yeong-Jin Jeon

Director

Jae-yeob Jeong

Director of Investment division

Lim Junki

Director, Chief Compliance Officer and CFO

Hyung-jun Kim

Partner

Seung Moon Lee

MD, Investment Associate

Seung-Mun Lee

Director

Gwi Jin Lee

MD and General Manager of Merger and Acquisition

Jun-Ki Lim

Director, Chief Compliances Officer and Head of Investment Management Division

Sung-yong Park

VP

Soo-yong Park

MD of the M&A Division

Dong-Joo Park

Director, Investment Review

Dong-ju Park

Director

Ha Jin Park

MD, Head of Investment Division 2

Hae Jin Park

MD, Head of Investment Team 1

Jeong-sun Song

Director

Min Hyun Yoon

MD and Investor General 1

Min-Hyeon Yoon

MD and Head of Investment Division 2

166 past transactions

M.Monstar

Series C in 2019
Developer of a corporate SI platform intended to offer a modular tool. The company offers omnichannel and mobile SCM to build SI (system integration) large shopping malls in a short period of time, enabling clients to integrate shopping mall management.

Birdview

Series B in 2018
BirdView Inc. develops and provides Internet based mobile application for marketed cosmetics' review and information. It offers iOS and Android based platform, HwaHae, which allows users to review details regarding each component of a product. The company is headquartered in South Korea.

BBB

Series B in 2018
BBB Technologies Inc. develops devices and applications that enable early stage diagnosis, better care, and treatment decisions. It creates blood testing technologies with mobile enabled tools and data insights for researchers, doctors, and patients worldwide. The company was founded in 2014 and is based in Mountain View, California with additional offices in Seoul, South Korea; and Shenzhen, China.

mangrove

Venture Round in 2023
Operator of a real-estate company intended to build large-scale shared housing. The company's real-estate services thrive to build an aspiring space based upon connections between individuals, enabling users to create a city that is good for living.

Bioplus Co.

Venture Round in 2005
Bioplus Co. creates bio-goods that promote the pursuit of beauty and contribute significantly to the well-being of the country.

Adbiotech

Venture Round in 2002
Adbiotech is a company that leaps toward the future with continuous challenges. Adbiotech is a research institute affiliated with the Korea Industrial Technology Association to research and develop antibody products, cosmetics and food additives for oral administration of pharmaceuticals, livestock and fisheries using egg yolk antibody (IgY) technology. Was established. They are leading national research projects for new and diverse products with the aim of "our food safe" through industry-academic cooperation.

Aptamer Sciences

Venture Round in 2013
Aptamer Sciences, Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. The company’s aptamer platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics. It offers AlloMAp and BiFAp platform programs for therapeutics; and diagnosis kits for lung and pancreatic cancer, as well as in-vitro diagnostic kits for the early diagnosis of lung cancer. Aptamer Sciences, Inc. was founded in 2011 and is headquartered in Seongnam, South Korea.

ITM Semiconductor

Venture Round in 2002
ITM Semiconductor Co., Ltd. manufactures and sells components for secondary batteries worldwide. Its products include protection one chips, protection module packages, battery packs, sensor module packages, chip antennas, and touch screen panels for use in IT portable and consumer devices. The company was formerly known as ITM Co., Ltd and changed its name to ITM Semiconductor Co., Ltd. in April 2005. ITM Semiconductor Co., Ltd. was founded in 2000 and is headquartered in Cheongju, South Korea. ITM Semiconductor Co., Ltd. is a subsidiary of NICE Holdings Co., Ltd.

Millie

Venture Round in 2018
Book Club Millie Co., Ltd. provides an e-book subscription platform. The company is based in Seoul, South Korea.

Telofarm

Venture Round in 2019
Telofarm provides the ultimate precision farming solution with microsensors. They provide high precision sensors and farming solutions for advanced agriculture and research in various needs. Their proprietary technology enabled microsensors on needle probes that can be implanted into plant stems to measure electrical conductivity and sap flow speed with minimum invasion. They have demonstrated the world's first full feedback control of irrigation in an advanced hydroponics with unprecedented efficiencies such as zero drain rate with improved quality and quantity of fruits.

ME2ZEN

Venture Round in 2018
ME2ZEN Limited develops and operates social casino and card games in North America, Europe, and Asia. It develops mobile casino games and solitaire games. The company is headquartered in Kwun Tong, Hong Kong.

Anyfive

Venture Round in 2005
ANYFIVE Co.,Ltd. provides intellectual property-research and development (IP-R&D) software solutions and information and communications technology (ICT) services for research institutes and enterprises in the field of intellectual property. The company offers IPR management solutions, including IP-Brain, IPIMS, and SmartTM; legal management software solutions, including SmartLMS and IPAMS; IPR risk analysis solutions, including P-Brain; technology commercialization solutions, including T-Brain; research and development solutions, including E-Brain, R-Brain, and SmartLAB; and bigdata and artificial intelligence solutions, including ANYFAST and A-Brain. It serves IPR services and ICT services. ANYFIVE Co.,Ltd. was founded in 2003 and is headquartered in Seoul, South Korea. It has a branch office in Daejeon, South Korea.

P&H TECH

Venture Round in 2011
P&H Tech Co., Ltd. develops, produces, and sells organic light emitting diode (OLED) materials and catalysts. The company offers general, EBL, HTL, host, OLED intermediate and catalyst, and other organic synthetic materials. It sells its products to the OLED display market. The company was founded in 2009 and is headquartered in Yongin, South Korea.

Anapass

Venture Round in 2004
AnaPass Inc. operates as a system-on chip semiconductor provider in display panel market worldwide. It designs and produces IC products applied to flat panel display and mobile devices based on its high-speed serial link technologies. The company’s flat panel display solutions include Timing Controller, an IC that receives video signal from the system interface and generates/transmits control signal/date to the source driver ICs and gate driver ICs that drives a LCD panel. Its mobile display solutions comprise Mobile Serial Link, an IC, which reduces power consumption, EMI noise, and cost; and Mobile Display Controller, an IC that is applied on mobile devices to process complex data signals and transmit them to display parts. The company was formerly known as Anachips, Inc. and changed its name to AnaPass Inc. in March 2004. AnaPass Inc. was founded in 2002 and is based in Seoul, South Korea.

GmoneyTrans

Venture Round in 2018
Operator of a digital wallet intended to offer cross-border money transfers. The company's wallet provides remittance services to many countries around the world through its multinational remittance partners, enabling users to send, receive, and make payments overseas and manage deposits and withdrawals globally.

ESTsecurity

Private Equity Round in 2021
ESTsecurity Corp. develops artificial intelligence security software. The company offers end point security, android security, threat intelligence, and hybrid-VDI. ESTsecurity Corp. was founded in 2017 and is based in Seoul, South Korea. ESTsecurity Corp. operates as a subsidiary of ESTsoft Corp.

True Balance

Series C in 2019
True Balance is a digital wallet owned and operated by Balancehero India Private Limited (BHI), that enables users to access utility bill payment, loan recharge, insurance, and other financial products. With 70 million users, True Balance aims to serve India with utility payments financial platform for the unbanked users to serve their money for living requirements. It was launched in 2014 by Mr. Charlie Lee as CEO, an alumnus of the University of Chicago.

Curiox Biosystems

Series B in 2019
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.

Okxe

Series A in 2020
OKXE VIETNAM COMPANY LIMITED operates an online e-commerce platform for motorbikes. The platform enables users to buy and sell motorcycles online. The company was founded in 2018 and is based in Hanoi, Vietnam.

Vuno

Series B in 2018
Vuno offers artificial intelligence-based medical solutions for doctors and patients that provides a platform and consulting services for medical data analysis. Vuno develops automatic algorithm against various problems that occurs in medical sites as well as it develops diagnostic and quantification assisting software. The clients of the company are Asan Medical Center and HYUNDAI. The company offers VunoMed that provides different forms of data analyzation for medical videos, ECGs, brain waves, and EMR data. Vuno is located in South Korea and the company was founded in 2014 by Yeha Lee, Kyu-Hwan Jung, and Dannis Kim.

MakinaRocks

Series A in 2020
Founded in December 2017, MakinaRocks is a startup specializing in industrial machine intelligence solutions. Our anomaly detection model and intelligent control algorithm analyze sensor and numeric data to provide intelligent control, improve product quality, and detect anomalies in manufacturing equipment. We deliver our industrial AI solutions to manufacturing industries such as semiconductor, automotive, battery, and energy.

Balance Hero Co., Ltd.

Private Placement in 2019
Balance Hero Co., Ltd. develops mobile applications for providing remaining balance to prepaid mobile customers. The company was founded in 2014 and is based in South Korea.

HonestFund

Series B in 2018
HonestFund is a financial technology company operating an alternative investing platform in South Korea. HonestFund provides individuals and institutional investors access to alternative investment opportunities across a wide range of asset classes, such as residential/commercial real estates, infrastructure financing and unsecured personal loans. Due to its unique capability of providing a fully transparent and frictionless process for both investors and private issuers, HonestFund raised funds from leading financial institutions, including Shinhan Bank, Hanwha Investment, KB Investment, Shinhan Capital and Daily Financial Group.

Crowdworks

Series B in 2019
CrowdWorks, Inc. develops online crowd sourcing platform for artificial intelligent (AI) which engages in collecting, strengthening, and structuring leaning data for machine learning. The company offers its services for analysis and classifying of image works, text works, voice works, and survey works. The company is based in Seoul, South Korea.

MakinaRocks

Private Placement in 2020
Founded in December 2017, MakinaRocks is a startup specializing in industrial machine intelligence solutions. Our anomaly detection model and intelligent control algorithm analyze sensor and numeric data to provide intelligent control, improve product quality, and detect anomalies in manufacturing equipment. We deliver our industrial AI solutions to manufacturing industries such as semiconductor, automotive, battery, and energy.

Mobiis

Private Placement in 2018
Mobiis Co., Ltd. designs and builds equipment and systems to monitor and control the particle accelerator beams and related equipment in South Korea. The company provides control system and equipment, including low-level radio frequency, solid state amp, and undulator controllers, as well as step motor controllers; nuclear fusion reactor control systems, such as control data access and communication framework service system, central interlock system, and coil power supply system; and intelligent control solutions. Mobiis Co., Ltd. was founded in 2000 and is based in Seongnam, South Korea.

ILIAS Biologics

Series B in 2020
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules. The company features platform technology that enables experts to load large therapeutic molecules into exosomes. ILIAS Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.

Odd Concepts

Private Placement in 2020
Odd Concepts Inc. develops computer vision and artificial intelligence technology solutions. The company’s products include an image recognition platform which is a portfolio of ready to use image recognition and search technology, as a cloud based API service and computer vision consulting. It develops an online software technology for video content searches to link offline shopping businesses to create O2O market. The company was incorporated in 2012 and is based in Seoul, South Korea.

Curiox Biosystems

Private Placement in 2019
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.

Well Marker Bio Co., Ltd.

Private Placement in 2019
Well Marker Bio Co., Ltd. researches, develops, and manufactures anticancer drugs. The company was founded in 2016 and is headquartered in Seoul, South Korea.

AITRICS

Series B in 2024
AITRICS is taking on the ultimate role of giving everyone access to the power of data-driven health intelligence by developing advanced clinical solutions that will revolutionize their lives. With a shared vision and a common purpose, passionate and dedicated professionals from diverse backgrounds came together to create the most exceptional team.

Millie

Series C in 2019
Book Club Millie Co., Ltd. provides an e-book subscription platform. The company is based in Seoul, South Korea.

Millie

Series B in 2018
Book Club Millie Co., Ltd. provides an e-book subscription platform. The company is based in Seoul, South Korea.

Novelty Nobility

Series B in 2022
Novelty Nobility Inc. is a private biotech company. They are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and oncology, where angiogenesis plays a key pathogenic role. In ophthalmology, Novelty Nobility first discovered a novel angiogenesis target, Stem Cell Factor(SCF) and c-KIT, which was initially known for its engagement with proliferation and survival of primitive hematopoietic stem cells for a couple of past decades. We believe that anti-SCF/c-KIT could effectively address the unmet medical needs, mostly caused by inherent limitations of anti-VEGFs, in terms of treatment efficacy and long-term safety. Our target discovery is widely and strongly patent-protected in US/KOR and the lead pipeline, NN2101(a full-human monoclonal antibody), is currently under preclinical development.

Novelty Nobility

Series B in 2021
Novelty Nobility Inc. is a private biotech company. They are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and oncology, where angiogenesis plays a key pathogenic role. In ophthalmology, Novelty Nobility first discovered a novel angiogenesis target, Stem Cell Factor(SCF) and c-KIT, which was initially known for its engagement with proliferation and survival of primitive hematopoietic stem cells for a couple of past decades. We believe that anti-SCF/c-KIT could effectively address the unmet medical needs, mostly caused by inherent limitations of anti-VEGFs, in terms of treatment efficacy and long-term safety. Our target discovery is widely and strongly patent-protected in US/KOR and the lead pipeline, NN2101(a full-human monoclonal antibody), is currently under preclinical development.

MX Bio

Series A in 2019
MX Bio is a MedTech startup that is addressing periodontal disease, also known as gum disease, an ailment that affects approximately 11.2% of the world’s population. MX Bio has developed a suite of three complimentary solutions to help prevent periodontal disease, and to cure it once it becomes a problem: 1. A biodegradable chip that is inserted between the teeth and releases medication in a controlled manner during one week of effective, efficient treatment, killing the germs that cause periodontal disease. 2. A compound antibiotic ointment that has completed successful preclinical trials. 3. An ointment and membrane type periodontal regeneration inducer. MX Bio's solutions have been developed with ultimate efficacy in mind. The company can deliver them for around 30% of the current market price, across the product range.

Dabeeo

Series A in 2019
Dabeeo is a platform that offers services of map technology with positioning and geospatial data technology with AI. They use vision data produced through smartphone cameras to create interactive maps, used for gaming, marketing, and logistics.

Bbodek

Series B in 2022
BBodek provides tableware rental services in Korea. The company is based in Seoul, South Korea.

M.Monstar

Series B in 2018
Developer of a corporate SI platform intended to offer a modular tool. The company offers omnichannel and mobile SCM to build SI (system integration) large shopping malls in a short period of time, enabling clients to integrate shopping mall management.

Odd Concepts

Series B in 2020
Odd Concepts Inc. develops computer vision and artificial intelligence technology solutions. The company’s products include an image recognition platform which is a portfolio of ready to use image recognition and search technology, as a cloud based API service and computer vision consulting. It develops an online software technology for video content searches to link offline shopping businesses to create O2O market. The company was incorporated in 2012 and is based in Seoul, South Korea.

Sharetreats

Series B in 2022
Sharetreats Innovation develops a platform through which consumers can send or receive vouchers which can be then redeemed at select nearest branch. The treat codes are sent via SMS after the payment is done. The company is headquartered in Makati, Philippines.

Sharetreats

Series A in 2019
Sharetreats Innovation develops a platform through which consumers can send or receive vouchers which can be then redeemed at select nearest branch. The treat codes are sent via SMS after the payment is done. The company is headquartered in Makati, Philippines.

Kukdong

Venture Round in 2001
Kukdong Corporation manufactures and sells knit garments for men, women, and children in South Korea. It also offers workwear; activewear, such as training wear, golf wear, and fitness wear; lounge wear, including home wear, room wear, sleep wear, and night gown; and fashion wear. The company also exports its products in the United States, the European Union, and Chile. Kukdong Corporation was founded in 1967 and is based in Seoul, South Korea.

Dt&C

Venture Round in 2001
DT&C Co., Ltd. provides testing and certification services. The company offers testing and certification services for information and communication technology equipment, industrial equipment, household/commercial consumer electronic products, medical devices, automotive electronic apparatus, nuclear power equipment, and vessels, as well as for defense, aerospace, and railway sectors. DT&C Co., Ltd. was founded in 1999 and is based in Yongin, South Korea.

MegaGen Implant

Venture Round in 2004
Megagen Implant Co., Ltd. manufactures dental instruments and equipment. It offers CNCs, three-dimensional laser measuring instruments, sand blasters, automatic washing devices, and implants. The company was formerly known as MegaGen Co., Ltd. and changed its name to MegaGen Implant Co., Ltd. in December 2007. The company was founded in 2002 and is based in Daegu, South Korea.

mangrove

Series B in 2021
Operator of a real-estate company intended to build large-scale shared housing. The company's real-estate services thrive to build an aspiring space based upon connections between individuals, enabling users to create a city that is good for living.

L & C BIO

Venture Round in 2013
L & C Bio Co., Ltd. is making the health and happiness of mankind based on their mission to improve the quality of human life and to give better value to their customers. And the efforts of L & C Bio Co., Ltd. start with the business philosophy of 'respecting customers', 'grasping needs' and 'providing the best products and services

AptaBio Therapeutics

Venture Round in 2011
AptaBio Therapeutics Inc. discovers and develops selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company offers Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX Reagent for transfecting DNA or RNA into eukaryotic cells. Its product candidates include PX-115 for treating diabetic nephropathy; APX-1004 to treat diabetic retinopathy; and APX-311 for use in treating non-alcoholic steatohepatitis (NASH). The company was founded in 2009 and is based in Yongin-Si, South Korea.

ATGC

Venture Round in 2012
ATGC Co., Ltd. engages in research and development of biopharmaceuticals. The company was founded in 2010 and is headquartered in Seongnam, South Korea.